U.S. Artificial Organs And Bionics Market Size & Outlook
Related Markets
U.S. artificial organs and bionics market highlights
- The U.S. artificial organs and bionics market generated a revenue of USD 13,124.6 million in 2022 and is expected to reach USD 24,054.9 million by 2030.
- The U.S. market is expected to grow at a CAGR of 7.9% from 2023 to 2030.
- In terms of segment, artificial organ was the largest revenue generating product in 2022.
- Artificial bionics is the most lucrative product segment registering the fastest growth during the forecast period.
Artificial organs and bionics market data book summary
| Market revenue in 2022 | USD 13,124.6 million |
| Market revenue in 2030 | USD 24,054.9 million |
| Growth rate | 7.9% (CAGR from 2022 to 2030) |
| Largest segment | Artificial organ |
| Fastest growing segment | Artificial bionics |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Artificial Organ, Artificial bionics |
| Key market players worldwide | Zimmer Biomet Holdings Inc, Boston Scientific Corp, Cochlear Ltd, Edwards Lifesciences Corp, Ekso Bionics Holdings Inc, Medtronic PLC, Symbotic Inc Ordinary Shares - Class A, Johnson & Johnson, Berlin Heart GmbH, SynCardia Systems |
Other key industry trends
- In terms of revenue, U.S. accounted for 38.3% of the global artificial organs and bionics market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. artificial organs and bionics market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 5,360.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Artificial Organs And Bionics Market Scope
Artificial Organs And Bionics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| SynCardia Systems | View profile | 101-250 | Tucson, Arizona, United States, North America | http://www.syncardia.com/ |
| Berlin Heart GmbH | View profile | 501-1000 | Berlin, Berlin, Germany, Europe | http://www.berlinheart.de/ |
| Symbotic Inc Ordinary Shares - Class A | View profile | 1300 | 200 Research Drive, Wilmington, MA, United States, 01887 | https://www.symbotic.com |
| Edwards Lifesciences Corp | View profile | 19800 | One Edwards Way, Irvine, CA, United States, 92614 | https://www.edwards.com |
| Cochlear Ltd | View profile | 4773 | 1 University Avenue, Macquarie University, Sydney, NSW, Australia, 2109 | https://www.cochlear.com |
| Ekso Bionics Holdings Inc | View profile | 72 | 101 Glacier Point, Suite A, San Rafael, CA, United States, 94901 | https://www.eksobionics.com |
| Zimmer Biomet Holdings Inc | View profile | 18000 | 345 East Main Street, Warsaw, IN, United States, 46580 | https://www.zimmerbiomet.com |
| Boston Scientific Corp | View profile | 48000 | 300 Boston Scientific Way, Marlborough, MA, United States, 01752-1234 | https://www.bostonscientific.com |
| Medtronic PLC | View profile | 95000 | Lower Hatch Street, 20 On Hatch, Dublin, Ireland, 2 | https://www.medtronic.com |
| Johnson & Johnson | View profile | 134400 | One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 | https://www.jnj.com |
U.S. artificial organs and bionics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to artificial organs and bionics market will help companies and investors design strategic landscapes.
Artificial organ was the largest segment with a revenue share of 70.26% in 2022. Horizon Databook has segmented the U.S. artificial organs and bionics market based on artificial organ, artificial bionics covering the revenue growth of each sub-segment from 2018 to 2030.
In North America, the U.S. dominated the market owing to a large patient pool, favorable reimbursement policies, and an increase in the number of organ transplantation procedures. A large number of people on the waiting list, coupled with technological advancements in the field of artificial organs, is expected to drive the market.
The number of organ donors in the U.S. has increased significantly over the past decade. According to the U.S. Department of Health & Human Services, there was a 40% increase in the number of organ donors from 2011 to 2019. Growing demand for kidney transplantation is one of the major market drivers.
Kidney transplantation witnessed exponential growth, from 16,186 transplants in 2011 to 23,401 transplants in 2019. An increase in the aging population is also boosting the need for artificial organs. The number of organ transplants in individuals older than 65 years in 2020 is almost double as compared to 2011.
Reasons to subscribe to U.S. artificial organs and bionics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. artificial organs and bionics market databook
-
Our clientele includes a mix of artificial organs and bionics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. artificial organs and bionics market, including forecasts for subscribers. This country databook contains high-level insights into U.S. artificial organs and bionics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. artificial organs and bionics market size, by product, 2018-2030 (US$M)
U.S. Artificial Organs And Bionics Market Share, 2022 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
